XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
REVENUE (Tables)
6 Months Ended
Apr. 30, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:
Three Months Ended April 30,
20242023
Life Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
TotalLife Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
Total
(in millions)
Revenue by Region
Americas$240 $167 $230 $637 $263 $154 $259 $676 
Europe188 111 127 426 207 103 123 433 
Asia Pacific326 124 60 510 404 130 74 608 
Total$754 $402 $417 $1,573 $874 $387 $456 $1,717 
Six Months Ended April 30,
20242023
Life Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
TotalLife Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
Total
(in millions)
Revenue by Region
Americas$484 $331 $452 $1,267 $549 $308 $506 $1,363 
Europe412 222 250 884 446 201 242 889 
Asia Pacific704 254 122 1,080 822 259 140 1,221 
Total$1,600 $807 $824 $3,231 $1,817 $768 $888 $3,473 
The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
Three Months EndedSix Months Ended
April 30,April 30,
2024202320242023
(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical$542 $612 $1,107 $1,251 
Chemicals and Advanced Materials362 378 754 784 
Diagnostics and Clinical239 250 467 489 
Food139 161 296 321 
Academia and Government139 159 289 305 
Environmental and Forensics152 157 318 323 
Total$1,573 $1,717 $3,231 $3,473 
Revenue by Type
Instrumentation$548 $689 $1,178 $1,448 
Non-instrumentation and other1,025 1,028 2,053 2,025 
Total$1,573 $1,717 $3,231 $3,473 
Contract Liabilities and Changes in Balances
The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the six months ended April 30, 2024:
Contract
Liabilities
(in millions)
Ending balance as of October 31, 2023$616 
Net revenue deferred in the period393 
Revenue recognized that was included in the contract liability balance at the beginning of the period(350)
Change in deferrals from customer cash advances, net of revenue recognized(6)
Currency translation and other adjustments
Ending balance as of April 30, 2024$654